Cardiovascular, kidney and metabolic outcomes
A practical route into outcomes trials spanning heart failure, chronic kidney disease and diabetes-driven cardiovascular risk.
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ – CVOT)
Survodutide injection reduces cardiovascular events in overweight or obese adults with heart or kidney disease compared to placebo.
View trial →Study to Collect High-Resolution ECG Data and Patient Insights on Heart Failure Care
The purpose of this study is to establish an electrocardiogram (ECG) data library to facilitate future studies on heart disease. Additionally, the…
View trial →Study to Collect High-Resolution ECG Data and Patient Insights on Heart Failure Care
The purpose of this study is to establish an electrocardiogram (ECG) data library to facilitate future studies on heart disease. Additionally, the…
View trial →